Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
AH Bio Fund IV, L.P. | Buy | Aug 7, 2026 | 9.13M | - | - | Form 4 ↗ |
AH Bio Fund IV, L.P. | Buy | Aug 7, 2026 | 1.10M | $18.00 | $19.80M | Form 4 ↗ |
Chimovits Erez | Buy | Aug 7, 2026 | 9.13M | - | - | Form 4 ↗ |
Chimovits Erez | Buy | Aug 7, 2026 | 1.67M | $18.00 | $30.00M | Form 4 ↗ |
Chimovits Erez | Buy | Aug 7, 2026 | 273.3K | $18.00 | $4.92M | Form 4 ↗ |
ORBIMED ADVISORS LLC | Buy | Aug 7, 2026 | 9.13M | - | - | Form 4 ↗ |
ORBIMED ADVISORS LLC | Buy | Aug 7, 2026 | 1.67M | $18.00 | $30.00M | Form 4 ↗ |
ORBIMED ADVISORS LLC | Buy | Aug 7, 2026 | 273.3K | $18.00 | $4.92M | Form 4 ↗ |
Jiangsu Hengrui Pharmaceuticals Co., Ltd. | Buy | Aug 7, 2026 | 7.42M | - | - | Form 4 ↗ |
Forbion Growth Opportunities Fund III Cooperatief U.A. Insider | Buy | Aug 7, 2026 | 9.13M | $0.00 | $0 | Form 4 ↗ |
Forbion Growth Opportunities Fund III Cooperatief U.A. Insider | Buy | Aug 7, 2026 | 7.99M | $0.00 | $0 | Form 4 ↗ |
Forbion Growth Opportunities Fund III Cooperatief U.A. Insider | Buy | Aug 7, 2026 | 1.92M | $18.00 | $34.56M | Form 4 ↗ |
Forbion Growth Opportunities Fund III Cooperatief U.A. Insider | Buy | Aug 7, 2026 | 1.68M | $18.00 | $30.24M | Form 4 ↗ |
Rickey James Paul Chief Financial Officer | Buy | Aug 7, 2026 | 27.8K | $18.00 | $500K | Form 4 ↗ |
Viehbacher Christopher Director | Buy | Aug 7, 2026 | 83.3K | $18.00 | $1.50M | Form 4 ↗ |
Malek David I Director | Buy | Aug 7, 2026 | 4.2K | $18.00 | $75K | Form 4 ↗ |
Anderson Michele A. Chief Development Officer | Buy | Aug 7, 2026 | 1.1K | $18.00 | $20K | Form 4 ↗ |
Murdoch Travis CEO and President | Buy | Aug 7, 2026 | 83.3K | $18.00 | $1.50M | Form 4 ↗ |